All lobbying filings

CAPITOL COUNSEL LLC

CAPITOL COUNSEL LLC filed a Q4 report for IPSEN BIOPHARMACEUTICALS, INC. on January 18, 2026, reporting $30,000 in lobbying income.

Lobbying for IPSEN BIOPHARMACEUTICALS, INC. · Biopharmaceutical company.

All filings by CAPITOL COUNSEL LLC · Everything IPSEN BIOPHARMACEUTICALS, INC. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 18, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Ensure Medicare beneficiary access to Medicare covered prescription drugs and enable beneficiaries to spread cost-sharing requirements, including monitor implementation of related provisions in the Inflation Reduction Act, P.L. 117-169.

Taxation/Internal Revenue Code

Issues related to international tax.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.